8 niðurstöður
BACKGROUND OF THE INVENTION
1. Field of the Invention
The present invention relates to the use of Coenzyme Q.sub.10 (or ubiquinone Q.sub.10 or quinone Q.sub.10, CoQ.sub.10) or functionally equivalent derivatives thereof, for the prevention, the treatment and/or attenuation of degenerative ocular
TECHNICAL FIELD
The present application relates generally to dietary supplements and, more particularly, to dietary supplements containing a fullerene complex that may decrease multi-system symptoms of inflammation and aging in vivo.
BACKGROUND
The "old paradigm" of disease management reflects a
TECHNICAL FIELD
This invention describes a nutritional composition and method of use for prevention of Parkinson's disease, therefore relating to the fields of nutrition, pharmacology, neurology, pathophysiology, medicine and movement disorders.
DESCRIPTION OF THE RELATED ART
Parkinson's disease
FIELD OF THE INVENTION
The present invention relates to the field of cannabinoids. More specifically, the present invention describes the medical use of some quinonoid derivatives of cannabinoids, as well as some such novel compounds.
BACKGROUND OF THE INVENTION
All publications mentioned throughout
This application claims the benefit of U.S. Provisional application Ser. No. 60/946, filed Jul. 1, 1996.
FIELD OF THE INVENTION
The present invention relates generally to a nontoxic extract of Larrea tridentata plant material having therapeutic value and a method of making the same. The present
FIELD OF THE INVENTION
The present invention relates generally to a nontoxic extract of Larrea tridentata plant material having therapeutic value and a method of making the same. The present invention also relates to the field of nontoxic, stable NDGA products used as food additives and therapeutic
FIELD OF THE INVENTION
The present invention relates generally to a nontoxic extract of Larrea tridentate plant material having therapeutic value and a method of making the same. The present invention also relates to the field of nontoxic, stable NDGA products used as food additives and therapeutic
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a 35 U.S.C. .sctn.371 National Stage of International Application No. PCT/IL2007/000836 filed on Jul. 4, 2007, which designates the United States, and which claims the benefit under 35 U.S.C. .sctn.119 (e) of U.S. Provisional Application